,7,37 In this study, we expand upon these previous findings by demonstrating that higher levels of genetically predicted MSMB are associated with a 20% lower risk of overall prostate cancer in two independent European ancestry cancer GWAS, and confirm its protective role in both aggressive and early onset disease aetiology. Here, MSMB is linked to prostate cancer.